[EN] NOVEL 2H-INDAZOLES AS EP2 RECEPTOR ANTAGONISTS<br/>[FR] NOUVEAUX 2H-INDAZOLES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR EP2
申请人:BAYER IP GMBH
公开号:WO2013079425A1
公开(公告)日:2013-06-06
The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2- receptor.
Disclosed are compounds of Formula 1, N-oxides, and salts thereof,
wherein
Q is O or S;
Z
1
and Z
2
are each independently CR
9
or N; and
R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
and R
9
are as defined in the disclosure.
Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP
2
-receptor.